GGrantIndex
Sort

146,196 grants matching diabetes

Impact of malatonin, food timing and receptor variant on type 2 diabetes risk

$677,280
Richa Saxena · Massachusetts General Hospital · R01 · FY2016 · DK

Modes of Cannabis Administration and Polysubstance Use among Women Before and During Pregnancy

$677,280
Kelly Corinne Young-Wolff · Kaiser Foundation Research Institute · R01 · FY2025 · DA

Acitivity for Diabetic Polyneuropathy: The ADAPT Study

$677,268
John Robinson Singleton · University Of Utah · R01 · FY2016 · DK

Mediators of Atherosclerosis in South Asians Living in America

$677,254
Alka M Kanaya · University Of California, San Francisco · R01 · FY2013 · HL

Native American Youth Cardiovascular Disease Prevention: Implementation of Culturally-Tailored Evidence-Based After School and Home Visitation Programs for Healthy Eating and Physical Activity

$677,226
Simone A French · University Of Minnesota · P50 · FY2023 · MD

Genetics of Response to Canagliflozin

$677,220
Simeon I Taylor · University Of Maryland Baltimore · R01 · FY2021 · DK

Studies of the Immunopathogenesis of Type 1 Diabetes

$677,195
Medical College Of Georgia (Mcg) · R01 · FY2003 · HD

New regulators of lipid metabolism in immature cardiomyocytes

$677,167
Kent L.r. Thornburg · Oregon Health & Science University · R01 · FY2019 · HL

Central Pain Mechanisms, Pain Intensity and Drug Response in Rheumatoid Arthritis

$677,152
Yvonne Claire Lee · Brigham And Women'S Hospital · R01 · FY2013 · AR

Genomic and Metabolomic Profiling of Finnish Familial Dyslipidemia Families

$677,127
Nelson B Freimer · University Of California Los Angeles · R01 · FY2015 · HL

Understanding Cross-National Health Differences at Older Ages and Their Causes

$677,125
Axel H Boersch-Supan · National Bureau Of Economic Research · R01 · FY2019 · AG

Using Peer Support To Aid in PRevention and Treatment in Prediabetes (UPSTART)

$677,122
Julie A Schmittdiel · Kaiser Foundation Research Institute · R18 · FY2018 · DK

Restoring Central Regulation of Glucose Production in Type 2 Diabetes

$677,112
Meredith A Hawkins · Albert Einstein College Of Medicine · R01 · FY2025 · DK

Gluconeogenesis and Glycogenolysis - Role and Regulation

$677,102
Dale S Edgerton · Vanderbilt University · R01 · FY2025 · DK

Using Metabolomics to Understand CVD Risk in Women with a History of Preterm Delivery

$677,084
Kathryn M Rexrode · Brigham And Women'S Hospital · R01 · FY2024 · HL

Antibiotic Prophylaxis to Prevent Obesity-related Induction Complications in Nulliparae at Term (APPOINT 2.0)

$677,083
Stephanie Pierce · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2024 · HD

A genomic toolkit for functional interrogation of trait variation in an aquatic model

$677,073
Wesley Charles Warren · University Of Missouri-Columbia · R24 · FY2022 · OD

Glycemic Observation Using A1C for Gestational Diabetes Diagnosis

$677,060
Camille Elise Powe · Massachusetts General Hospital · R01 · FY2023 · HD

Low-Profile 3D-Printed Radiopaque Bioresorbable Vascular Scaffolds

$677,048
Guillermo A Ameer · Northwestern University · R01 · FY2022 · HL

Diabetes Prevention Program Outcomes Study - Phase 2

$676,963
Richard F Hamman · University Of Colorado Denver · U01 · FY2012 · DK

ACCTiVATE: Achieving Chronic Care equiTy by leVeraging the Telehealth Ecosystem

$676,956
Delphine Tuot · University Of California, San Francisco · R01 · FY2025 · MD

Development of Next-Generation Mass Spectrometry-based de novo RNA Sequencing for all Modifications

$676,946
Shenglong Zhang · New York Inst Of Technology · R01 · FY2023 · HG

Determining true versus apparent treatment-resistant hypertension among African Americans in the Jackson Heart Study

$676,943
Rikki M Tanner · University Of Alabama At Birmingham · R01 · FY2022 · HL

Targeting Senescence to Mitigate Chemotherapy-induced Functional Decline

$676,867
Mina S Sedrak · University Of California Los Angeles · R01 · FY2025 · CA

Social Stressors and Atherosclerosis in African-American Women with Lupus

$676,834
Ten㉠T Lewis · Emory University · R01 · FY2017 · AR